Semaglutide pilot trial to assess vascular, metabolic, and anti-inflammatory effects in non-diabetic PsA
GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis
Abstract
A pilot randomized trial will investigate semaglutide's vascular, metabolic, and anti-inflammatory effects in 40 non-diabetic psoriatic arthritis patients over 24 weeks.